84 related articles for article (PubMed ID: 3481138)
1. [Acute leukemia with blasts in the shape of a hand mirror].
Iavorskiĭ LI; Grasmane DV
Ter Arkh; 1987; 59(10):71-4. PubMed ID: 3481138
[TBL] [Abstract][Full Text] [Related]
2. Treatment of blast crisis of chronic myelogenous leukemia with vincristine, prednisone, and cytarabine.
Cervantes F; Rozman C; Bladé J; Montserrat E; Grañena A
Cancer Treat Rep; 1985; 69(7-8):923-4. PubMed ID: 3860299
[No Abstract] [Full Text] [Related]
3. Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia.
Dengler R; Plewan A; Münstermann U; Busch R; Eger G; Emmerich B
Clin Cancer Res; 1995 Feb; 1(2):199-205. PubMed ID: 9815974
[TBL] [Abstract][Full Text] [Related]
4. Reappearance of acute myeloid leukemia after almost 23 years of continuous complete remission.
Lee SH; Abebe L; Paietta E; Einzig A; Wiernik PH
Am J Hematol; 2009 Jul; 84(7):455-7. PubMed ID: 19507211
[No Abstract] [Full Text] [Related]
5. Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report.
Kansu E; Koc Y; Kars A; Alakavuklar M; Tekuzman G; Firat D
J Chemother; 1989 Jul; 1(4 Suppl):1268-70. PubMed ID: 16312861
[No Abstract] [Full Text] [Related]
6. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.
Creutzig U; Büchner T; Sauerland MC; Zimmermann M; Reinhardt D; Döhner H; Schlenk RF
Cancer; 2008 Feb; 112(3):562-71. PubMed ID: 18076087
[TBL] [Abstract][Full Text] [Related]
7. Rebound peripheral blastosis with subsequent remission during remission induction in a patient with acute promyelocytic leukemia.
Amato R; Kantarjian H; Walters R; Keating M
Cancer; 1988 Feb; 61(4):650-3. PubMed ID: 3422175
[TBL] [Abstract][Full Text] [Related]
8. Persistence of peripheral blood and bone marrow blasts during remission induction in adult acute lymphoblastic leukemia confers a poor prognosis depending on treatment intensity.
Cortes J; Fayad L; O'Brien S; Keating M; Kantarjian H
Clin Cancer Res; 1999 Sep; 5(9):2491-7. PubMed ID: 10499624
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia.
Gandhi V; Estey E; Du M; Nowak B; Keating MJ; Plunkett W
Clin Cancer Res; 1995 Feb; 1(2):169-78. PubMed ID: 9815970
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy with DATV regimen in treatment of adult acute nonlymphocytic leukemia.
Lou FD; Zhou Q; Liu HC; Meng FY; Wang YZ
Chin Med J (Engl); 1993 Nov; 106(11):876-8. PubMed ID: 8143502
[No Abstract] [Full Text] [Related]
11. Acute myeloid leukemia in adults: experience at AIIMS.
Raina V; Kochupillai V
J Assoc Physicians India; 1983 Aug; 31(8):511-4. PubMed ID: 6581155
[No Abstract] [Full Text] [Related]
12. Bone marrow morphology during induction phase of therapy for acute myeloid leukemia (AML).
Dick FR; Burns CP; Weiner GJ; Heckman KD
Hematol Pathol; 1995; 9(2):95-106. PubMed ID: 7559259
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.
Walker AR; Komrokji RS; Ifthikharuddin J; Messina P; Mulford D; Becker M; Friedberg J; Oliva J; Phillips G; Liesveld JL; Abboud C
Leuk Res; 2008 Dec; 32(12):1830-6. PubMed ID: 18571721
[TBL] [Abstract][Full Text] [Related]
14. The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.
Castagnola C; Nozza A; Corso A; Bernasconi C
Haematologica; 1997; 82(5):577-80. PubMed ID: 9407724
[TBL] [Abstract][Full Text] [Related]
15. [HOAP/HOAGP in the treatment of acute non-lymphocytic leukemia: an analysis of 68 cases].
Shan YD
Zhonghua Yi Xue Za Zhi; 1985 Oct; 65(10):590-2. PubMed ID: 3938671
[No Abstract] [Full Text] [Related]
16. Aberrant phenotype of plasmacytoid monocytes in acute myeloid leukemia.
Boveri E; Castagnola C; Castello A; Magrini U
Am J Hematol; 2008 May; 83(5):428-9. PubMed ID: 17617786
[No Abstract] [Full Text] [Related]
17. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.
Yalman N; Sarper N; Devecioğlu O; Anak S; Eryilmaz E; Can M; Yenilmez H; Ağaoğlu L; Gedikoğlu G
Turk J Pediatr; 2000; 42(3):198-204. PubMed ID: 11105617
[TBL] [Abstract][Full Text] [Related]
18. Gelatinous transformation of bone marrow following chemotherapy for myeloma.
Mathew M; Mathews I; Manohar C; Rao S
Indian J Pathol Microbiol; 2001 Jan; 44(1):53-4. PubMed ID: 12561997
[TBL] [Abstract][Full Text] [Related]
19. [A case of acute myelogenous leukemia accompanied with myelofibrosis and megakaryocyte-like giant bizarre blasts].
Yasunaga M; Hodohara K; Bamba F; Kitamura K; Fukuda M; Boku T; Miyagawa A; Inoue T; Kitoh K; Andoh A
Rinsho Byori; 1995 Oct; 43(10):1078-82. PubMed ID: 8531394
[TBL] [Abstract][Full Text] [Related]
20. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]